Skip to content

ALLERGAN INC

Delisted

CIK 850693fmd_08Y48RW6053K0ES37A0WYZF4NEManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2007 to Dec 31, 2014, 28 periods

Latest annual · FY2014

Millions
Total revenues
7,238
Operating income
2,009
Net income
1,524
Free cash flow
1,684

Latest quarter · Q4 FY2014

Millions
Total revenues
1,911
Operating income
627
Net income
537
Free cash flow
636
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2011 to FY2014
+11.5%
Revenue, 5 yearsFY2009 to FY2014
+10.0%
Net income, 5 yearsFY2009 to FY2014
+19.7%

ALLERGAN INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Revenue$7.2 billion$6.3 billion+14.9%10-K 2015-02-19 · proof
Operating income$2 billion$1.8 billion+11.1%10-K 2015-02-19 · proof
Net income$1.5 billion$985.1 million+54.7%10-K 2015-02-19 · proof
Cash from operating activities$1.9 billion$1.7 billion+13.7%10-K 2015-02-19 · proof
Free cash flow$1.7 billion$1.5 billion+10.5%10-K 2015-02-19 · proof
Total assets$12.4 billion$10.6 billion+17.4%10-K 2015-02-19 · proof
Total liabilities$4.7 billion$4.1 billion+13.3%10-K 2015-02-19 · proof
Cash and cash equivalents$4.9 billion$3 billion+61.2%10-K 2015-02-19 · proof
What was ALLERGAN INC's revenue in fiscal 2014?
ALLERGAN INC reported revenue of $7.2 billion for fiscal 2014 (the year ended Dec 31, 2014), against $6.3 billion the year before (+14.9%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC
What was ALLERGAN INC's operating income in fiscal 2014?
ALLERGAN INC reported operating income of $2 billion for fiscal 2014 (the year ended Dec 31, 2014), against $1.8 billion the year before (+11.1%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC
What was ALLERGAN INC's net income in fiscal 2014?
ALLERGAN INC reported net income of $1.5 billion for fiscal 2014 (the year ended Dec 31, 2014), against $985.1 million the year before (+54.7%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC
What was ALLERGAN INC's cash from operating activities in fiscal 2014?
ALLERGAN INC reported cash from operating activities of $1.9 billion for fiscal 2014 (the year ended Dec 31, 2014), against $1.7 billion the year before (+13.7%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC
What was ALLERGAN INC's free cash flow in fiscal 2014?
ALLERGAN INC reported free cash flow of $1.7 billion for fiscal 2014 (the year ended Dec 31, 2014), against $1.5 billion the year before (+10.5%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC
What are ALLERGAN INC's total assets?
As of Dec 31, 2014, ALLERGAN INC reported total assets of $12.4 billion, against $10.6 billion a year earlier (+17.4%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC
What are ALLERGAN INC's total liabilities?
As of Dec 31, 2014, ALLERGAN INC reported total liabilities of $4.7 billion, against $4.1 billion a year earlier (+13.3%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC
What are ALLERGAN INC's cash and cash equivalents?
As of Dec 31, 2014, ALLERGAN INC reported cash and cash equivalents of $4.9 billion, against $3 billion a year earlier (+61.2%). Source: the 10-K filed with the SEC on Feb 19, 2015. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:850693&period_type=annual&limit=5"

Information only, not investment advice.